Recombinant architecture in genomic program poses an interesting and concerning view of the future. As Bratton suggests, it is not that we should be concerned with the natural, physical body as we see and use it, but the foundation of society on much of what we have understood through the course of history concerning our bodies. Now that that definition is changing drastically, through biotechnological applications, the level of adaptation must be a quick response. Architectonically, the recombinant properties of materiality will undoubtedly relay into new forms. Bratton says as much in analyzing examples such as Greg Lynn’s Embryological House. This example is making a strong argument for redefining the body as a now affected presence, temporal in its qualities of ability and aesthetic. And so I would question whether architecture can now be solely reliant on its inhabitants to inform ability and performance. Will our bodies establish a governing rule for performative architecture or must our bodies transition between appropriate levels of space? Bratton may suggest that the space, with its recombinant capabilities, will allow the body to remain passive, but biotechnological abilities are already far advanced to the point where recombinant medical science may soon define how and what our bodies produce and become the recombinant architecture.